AAPL331.34-1.74 (-0.52%) ▼|ABBV263.04+1.27 (+0.49%) ▲|ABT102.13+0.10 (+0.10%) ▲|ACN189.09-4.31 (-2.23%) ▼|ADBE252.24-5.52 (-2.14%) ▼|AMAT424.00+2.83 (+0.67%) ▲|AMD520.51+16.31 (+3.23%) ▲|AMGN376.55+0.90 (+0.24%) ▲|AMT177.92+0.18 (+0.10%) ▲|AMZN247.52-0.91 (-0.36%) ▼|AVGO340.00+0.73 (+0.22%) ▲|AXP315.02-9.38 (-2.89%) ▼|BA209.91+0.26 (+0.12%) ▲|BAC58.46-1.03 (-1.73%) ▼|BKNG170.53-0.79 (-0.46%) ▼|BLK1,056.53-1.50 (-0.14%) ▼|BMY64.06+0.30 (+0.47%) ▲|BNY153.36-1.31 (-0.85%) ▼|BRK-B519.13+2.71 (+0.52%) ▲|C134.69-1.50 (-1.10%) ▼|CAT787.57+4.68 (+0.60%) ▲|CL87.42+0.39 (+0.45%) ▲|CMCSA24.29-0.13 (-0.53%) ▼|COF203.82-2.92 (-1.41%) ▼|COP136.45-4.78 (-3.38%) ▼|COST899.50-1.85 (-0.21%) ▼|CRM253.59-2.24 (-0.88%) ▼|CSCO110.66+0.59 (+0.53%) ▲|CVS93.97-0.51 (-0.54%) ▼|CVX213.80-3.93 (-1.80%) ▼|DE681.48-2.43 (-0.35%) ▼|DHR211.77+2.48 (+1.19%) ▲|DIS107.30+0.91 (+0.86%) ▲|DUK118.21+0.47 (+0.39%) ▲|EMR146.71-0.25 (-0.17%) ▼|FDX301.79-6.54 (-2.12%) ▼|GD357.30-1.33 (-0.37%) ▼|GE310.37+3.27 (+1.06%) ▲|GEV894.97+12.80 (+1.45%) ▲|GILD147.19+0.89 (+0.60%) ▲|GM84.59-0.78 (-0.91%) ▼|GOOG341.17-0.26 (-0.08%) ▼|GOOGL344.80-0.18 (-0.05%) ▼|GS968.87-7.64 (-0.78%) ▼|HD306.74+1.20 (+0.39%) ▲|HON205.53+2.09 (+1.02%) ▲|IBM241.89-6.51 (-2.62%) ▼|INTC104.17+7.03 (+7.24%) ▲|INTU322.08-7.19 (-2.18%) ▼|ISRG379.05+1.89 (+0.50%) ▲|JNJ267.80+0.92 (+0.34%) ▲|JPM351.04-2.58 (-0.73%) ▼|KO88.43-0.27 (-0.30%) ▼|LIN465.47+2.51 (+0.54%) ▲|LLY1,145.46+8.48 (+0.75%) ▲|LMT532.13-1.34 (-0.25%) ▼|LOW195.65+1.09 (+0.56%) ▲|LRCX272.65+1.78 (+0.66%) ▲|MA568.94-4.20 (-0.73%) ▼|MCD250.59-2.32 (-0.92%) ▼|MDLZ62.30+0.20 (+0.32%) ▲|MDT94.02+0.21 (+0.22%) ▲|META682.00+11.76 (+1.75%) ▲|MMM165.71+1.05 (+0.63%) ▲|MO70.23+0.42 (+0.60%) ▲|MRK144.23+0.44 (+0.31%) ▲|MS205.64-0.61 (-0.30%) ▼|MSFT493.90-3.22 (-0.65%) ▼|MU927.22-0.39 (-0.04%) ▼|NEE81.37+0.30 (+0.36%) ▲|NFLX77.55-0.35 (-0.45%) ▼|NKE36.41+0.19 (+0.52%) ▲|NOW139.61-2.26 (-1.59%) ▼|NVDA213.97+1.80 (+0.85%) ▲|ORCL142.63+2.26 (+1.61%) ▲|PEP135.72+0.22 (+0.16%) ▲|PFE27.63+0.09 (+0.31%) ▲|PG147.26+0.60 (+0.41%) ▲|PLTR170.95-1.62 (-0.94%) ▼|PM194.62+0.61 (+0.31%) ▲|QCOM189.53+1.73 (+0.92%) ▲|RTX195.43-0.08 (-0.04%) ▼|SBUX98.02+1.44 (+1.49%) ▲|SCHW106.52-1.28 (-1.19%) ▼|SO86.57+0.62 (+0.72%) ▲|SPG205.07+0.91 (+0.45%) ▲|T26.79+0.06 (+0.21%) ▲|TMO645.60+4.12 (+0.64%) ▲|TMUS180.19-0.28 (-0.16%) ▼|TSLA358.59+2.01 (+0.56%) ▲|TXN265.97+2.54 (+0.96%) ▲|UBER70.95-0.54 (-0.76%) ▼|UNH378.37+2.43 (+0.65%) ▲|UNP283.86-0.17 (-0.06%) ▼|UPS100.67-1.71 (-1.67%) ▼|USB61.31-0.94 (-1.50%) ▼|V373.93-1.75 (-0.46%) ▼|VZ51.39-0.06 (-0.12%) ▼|WFC88.25-1.48 (-1.64%) ▼|WMT107.91-0.19 (-0.17%) ▼|XOM166.15-3.12 (-1.84%) ▼|AAPL331.34-1.74 (-0.52%) ▼|ABBV263.04+1.27 (+0.49%) ▲|ABT102.13+0.10 (+0.10%) ▲|ACN189.09-4.31 (-2.23%) ▼|ADBE252.24-5.52 (-2.14%) ▼|AMAT424.00+2.83 (+0.67%) ▲|AMD520.51+16.31 (+3.23%) ▲|AMGN376.55+0.90 (+0.24%) ▲|AMT177.92+0.18 (+0.10%) ▲|AMZN247.52-0.91 (-0.36%) ▼|AVGO340.00+0.73 (+0.22%) ▲|AXP315.02-9.38 (-2.89%) ▼|BA209.91+0.26 (+0.12%) ▲|BAC58.46-1.03 (-1.73%) ▼|BKNG170.53-0.79 (-0.46%) ▼|BLK1,056.53-1.50 (-0.14%) ▼|BMY64.06+0.30 (+0.47%) ▲|BNY153.36-1.31 (-0.85%) ▼|BRK-B519.13+2.71 (+0.52%) ▲|C134.69-1.50 (-1.10%) ▼|CAT787.57+4.68 (+0.60%) ▲|CL87.42+0.39 (+0.45%) ▲|CMCSA24.29-0.13 (-0.53%) ▼|COF203.82-2.92 (-1.41%) ▼|COP136.45-4.78 (-3.38%) ▼|COST899.50-1.85 (-0.21%) ▼|CRM253.59-2.24 (-0.88%) ▼|CSCO110.66+0.59 (+0.53%) ▲|CVS93.97-0.51 (-0.54%) ▼|CVX213.80-3.93 (-1.80%) ▼|DE681.48-2.43 (-0.35%) ▼|DHR211.77+2.48 (+1.19%) ▲|DIS107.30+0.91 (+0.86%) ▲|DUK118.21+0.47 (+0.39%) ▲|EMR146.71-0.25 (-0.17%) ▼|FDX301.79-6.54 (-2.12%) ▼|GD357.30-1.33 (-0.37%) ▼|GE310.37+3.27 (+1.06%) ▲|GEV894.97+12.80 (+1.45%) ▲|GILD147.19+0.89 (+0.60%) ▲|GM84.59-0.78 (-0.91%) ▼|GOOG341.17-0.26 (-0.08%) ▼|GOOGL344.80-0.18 (-0.05%) ▼|GS968.87-7.64 (-0.78%) ▼|HD306.74+1.20 (+0.39%) ▲|HON205.53+2.09 (+1.02%) ▲|IBM241.89-6.51 (-2.62%) ▼|INTC104.17+7.03 (+7.24%) ▲|INTU322.08-7.19 (-2.18%) ▼|ISRG379.05+1.89 (+0.50%) ▲|JNJ267.80+0.92 (+0.34%) ▲|JPM351.04-2.58 (-0.73%) ▼|KO88.43-0.27 (-0.30%) ▼|LIN465.47+2.51 (+0.54%) ▲|LLY1,145.46+8.48 (+0.75%) ▲|LMT532.13-1.34 (-0.25%) ▼|LOW195.65+1.09 (+0.56%) ▲|LRCX272.65+1.78 (+0.66%) ▲|MA568.94-4.20 (-0.73%) ▼|MCD250.59-2.32 (-0.92%) ▼|MDLZ62.30+0.20 (+0.32%) ▲|MDT94.02+0.21 (+0.22%) ▲|META682.00+11.76 (+1.75%) ▲|MMM165.71+1.05 (+0.63%) ▲|MO70.23+0.42 (+0.60%) ▲|MRK144.23+0.44 (+0.31%) ▲|MS205.64-0.61 (-0.30%) ▼|MSFT493.90-3.22 (-0.65%) ▼|MU927.22-0.39 (-0.04%) ▼|NEE81.37+0.30 (+0.36%) ▲|NFLX77.55-0.35 (-0.45%) ▼|NKE36.41+0.19 (+0.52%) ▲|NOW139.61-2.26 (-1.59%) ▼|NVDA213.97+1.80 (+0.85%) ▲|ORCL142.63+2.26 (+1.61%) ▲|PEP135.72+0.22 (+0.16%) ▲|PFE27.63+0.09 (+0.31%) ▲|PG147.26+0.60 (+0.41%) ▲|PLTR170.95-1.62 (-0.94%) ▼|PM194.62+0.61 (+0.31%) ▲|QCOM189.53+1.73 (+0.92%) ▲|RTX195.43-0.08 (-0.04%) ▼|SBUX98.02+1.44 (+1.49%) ▲|SCHW106.52-1.28 (-1.19%) ▼|SO86.57+0.62 (+0.72%) ▲|SPG205.07+0.91 (+0.45%) ▲|T26.79+0.06 (+0.21%) ▲|TMO645.60+4.12 (+0.64%) ▲|TMUS180.19-0.28 (-0.16%) ▼|TSLA358.59+2.01 (+0.56%) ▲|TXN265.97+2.54 (+0.96%) ▲|UBER70.95-0.54 (-0.76%) ▼|UNH378.37+2.43 (+0.65%) ▲|UNP283.86-0.17 (-0.06%) ▼|UPS100.67-1.71 (-1.67%) ▼|USB61.31-0.94 (-1.50%) ▼|V373.93-1.75 (-0.46%) ▼|VZ51.39-0.06 (-0.12%) ▼|WFC88.25-1.48 (-1.64%) ▼|WMT107.91-0.19 (-0.17%) ▼|XOM166.15-3.12 (-1.84%) ▼|
18.7 C
New York
Wednesday, September 16, 2026

Tag: PER

newssourceFORcompanyinformationcontent1releasesmarket

Industrial Cleaning Solvents Market worth $1.55 billion by 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., June 20, 2025 /PRNewswire/ -- The report "Industrial Cleaning Solvents Market by Application (General & Medical Device Cleaning, Metal Cleaners, Disinfectants), End-use Industry (Manufacturing...

Ipsen receives positive CHMP opinion for Cabometyx® in previously treated advanced neuroendocrine tumors

PARIS, FRANCE, 20 June 2025 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for Cabometyx® (cabozantinib) for adult patients with unresectable or metastatic, well differentiated extra-pancreatic (epNET) and pancreatic (pNET) neuroendocrine tumors who have progressed following at least one prior systemic therapy other than somatostatin analogues. This recommendation is based on results from the CABINET Phase III trial presented at the European Society of Medical Oncology (ESMO) Congress 2024 and published in the New England Journal of Medicine.3,4 A final decision on the approval in the European Union is expected in the coming months.

The Week in Canadian Press Releases: 10 Stories You Need to See

A roundup of the most newsworthy press releases from Cision Distribution this week TORONTO, June 20, 2025 /CNW/ - With thousands of press releases published...

Bright Scholar Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

CAMBRIDGE, England and FOSHAN, China, June 20, 2025 /PRNewswire/ -- Bright Scholar Education Holdings Limited ("Bright Scholar" or the "Company") (NYSE: BEDU), a global...

MGI Tech Receives CE Mark for DNBSEQ-T1+ Sequencer

SHENZHEN, China, June 20, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation...

Prosafe SE: Operational update – May 2025

20 June 2025 - Fleet utilisation for May 2025 was 60 per cent.   

FinVolution Group Announces Proposed Offering of US$130 Million Convertible Senior Notes

SHANGHAI, June 19, 2025 /PRNewswire/ -- FinVolution Group ("FinVolution" or the "Company") (NYSE: FINV), a leading fintech platform in China, Indonesia and the Philippines,...

NORTHCLIFF ANNOUNCES NON-BROKERED PRIVATE PLACEMENT FINANCING

VANCOUVER, BC, June 19, 2025 /CNW/ - Northcliff Resources Ltd. ("Northcliff" or the "Company") (TSX: NCF) announces that it has arranged a non-brokered private...

National Bank of Canada Announces NVCC Subordinated Notes Offering

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./ MONTREAL, June 19, 2025 /CNW/ - National Bank of Canada...

HER2-low Cancers Market Set to Register Immense Growth at a CAGR of 9.4% During the Study Period (2020-2034) | DelveInsight

The future of the HER2-low cancer treatment market is poised for significant transformation, driven by the approval of ENHERTU and the advancement of other...

Delta-like Ligand 3 Targeted Therapies Market is Predicted to Heat Up During the Forecast Period (2025-2034) Across 7MM Owing to a Robust Pipeline |...

The delta-like ligand 3 targeted therapies market is witnessing significant growth, driven by the rising incidence of small cell lung cancer (SCLC) and neuroendocrine...

Northview Residential REIT Announces June Distribution

Not for distribution to U.S. newswire services or for dissemination in the United States.

Artemis Gold Announces Management Changes

TSXV: ARTG VANCOUVER, BC, June 19, 2025 /CNW/ - Artemis Gold Inc. (TSXV: ARTG) ("Artemis Gold" or the "Company") is pleased to announce the following...

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WARREN, N.J., June 19, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on June 16, 2025, the company approved non-statutory stock options...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPER

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers